Radiofrequency ablation for long- and ultralong-segment Barrett's esophagus: a comparative long-term follow-up study - 19/03/13
Reprint requests: Parambir S. Dulai, MD, Department of Medicine, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756Résumé |
Background |
The safety, efficacy, and durability of radiofrequency ablation (RFA), with or without EMR, have been established for long-segment Barrett's esophagus (LSBE). Ablating ultralong-segment Barrett's esophagus (ULSBE) may be associated with increased stricture formation, eradication failure, and treatment session requirements.
Objectives |
Our primary objective was to compare eradication and stricture rates between LSBE (≥3 to <8 cm) and ULSBE (≥8 cm). Our secondary objective was to evaluate treatment durability and session requirements.
Design |
Retrospective review of prospectively collected data.
Setting |
Tertiary care facility.
Patients |
A total of 72 patients (34 ULSBE, 38 LSBE; mean Barrett's segment length of 10.8 and 4.7 cm) underwent RFA between August 2005 and September 2010. Mean follow-up was 45 and 34 months, respectively.
Main Outcome Measurements |
Eradication and complication rates for ULSBE and LSBE.
Results |
Eradication rates for dysplasia (90% vs 88%, P = 1.0) and intestinal metaplasia (IM) (77% vs 82%, P = .77) were similar. ULSBE patients required more overall (P < .01) and circumferential (P < .01) RFA; however, stricture rates were identical (14%). There was no dysplasia recurrence, and IM recurrence was similar (ULSBE, 23%; LSBE, 16%; P = .52). At 3 years, IM remained eradicated in 65% of ULSBE and 82% of LSBE, without maintenance RFA. On multivariate regression analysis, increasing Barrett's length was associated with a reduced likelihood for eradicating IM (odds ratio 0.87; 95% CI, 0.75-1.00), but not dysplasia (odds ratio 1.13; 95% CI, 0.95-1.35).
Limitations |
Single center.
Conclusion |
ULSBE can be treated in its entirety at each session with efficacy and safety comparable to LSBE. ULSBE requires more effort to achieve IM eradication, and RFA is less durable in maintaining this eradication at 3-year follow-up.
Le texte complet de cet article est disponible en PDF.Abbreviations : BE, CE-D, CE-IM, HGD, IM, LSBE, RFA, ULSBE
Plan
| DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: Drs Rothstein and Gordon have received research support from BARRX Medical Inc (NEJM 2009 May;360(22):2277-88; Gastroenterology 2011 Aug;141(2):460-8). The other authors disclosed no financial relationships relevant to this publication. |
|
| If you would like to chat with an author of this article, you may contact Dr Dulai at Parambir.S.Dulai@hitchcock.org. |
Vol 77 - N° 4
P. 534-541 - avril 2013 Retour au numéro
Article précédent
- EUS-guided pancreatic cyst ablation: a critical review (with video)
- Hyoung-Chul Oh, William R. Brugge
- The role of high-resolution endoscopy and narrow-band imaging in the evaluation of upper GI neoplasia in familial adenomatous polyposis
- Maria Lopez-Ceron, Frank J.C. van den Broek, Elisabeth M. Mathus-Vliegen, Karam S. Boparai, Susanne van Eeden, Paul Fockens, Evelien Dekker
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?